NCT02562599
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Hubei Cancer hospital Wuhan, Hubei, China
Clinical trial condition
Otorhinolaryngologic Diseases
Explore clinical trials studying Otorhinolaryngologic Diseases. Study availability and eligibility vary by location and protocol.
5,448 public trials
862 recruiting studies
Otorhinolaryngologic Diseases trial results
Completed
DYmista NAsal Spray in CHInese Patients
NCT03599791
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +8 more
- Locations
-
- Investigational Site 2 Beijing, Beijing Municipality, China
- Investigational Site 3 Beijing, Beijing Municipality, China
- Investigational Site 4 Beijing, Beijing Municipality, China
- Investigational Site 5 Beijing, Beijing Municipality, China
NCT03004131
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- Inflamax Research Mississauga, Ontario, Canada
NCT03843580
- Conditions
- Anesthesia, Apnea, Apnea, Postanesthetic, +13 more
- Locations
-
- CaenUH Caen, Normandy, France
- Centre François Baclesse Caen, France
NCT00794846
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +10 more
- Locations
-
Not specified
Completed
Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)
NCT00794768
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
Not specified
NCT00805584
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
Not specified
NCT00794495
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +10 more
- Locations
-
Not specified
NCT00794248
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
Not specified
NCT00794599
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +10 more
- Locations
-
Not specified